From Agadez to Zinder: estimating coverage of the MenAfriVac™ conjugate vaccine against meningococcal serogroup A in Niger, September 2010 - January 2012. (Q39481684)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	From Agadez to Zinder: estimating coverage of the MenAfriVac™ conjugate vaccine against meningococcal serogroup A in Niger, September 2010 - January 2012.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

From Agadez to Zinder: estimating coverage of the MenAfriVac™ conjugate vaccine against meningococcal serogroup A in Niger, September 2010 - January 2012. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

0 references

author name string

Saverio Caini

1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Nam Seon Beck

2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Harouna Yacouba

3

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Idrissa Maiga

4

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Ibrahim Chaibou

5

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Ide Hinsa

6

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Aboubacar Adakal

7

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Aboubacar Issoufou

8

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Sung Hye Kim

9

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Lorenzo Pezzoli

10

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

language of work or name

0 references

publication date

19 January 2013

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1597-1603

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Where is the meningitis belt? Defining an area at risk of epidemic meningitis in Africa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.015

7 January 2021

Meningococcal carriage in the African meningitis belt

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.015

7 January 2021

Relationships between climate and year-to-year variability in meningitis outbreaks: a case study in Burkina Faso and Niger

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.015

7 January 2021

Climate drives the meningitis epidemics onset in west Africa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.015

7 January 2021

Increase in Neisseria meningitidis serogroup W135, Niger, 2010.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.015

7 January 2021

Emergency vaccination against epidemic meningitis in Ghana: Implications for the control of meningococcal disease in West Africa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.015

7 January 2021

Meningococcal glycoconjugate vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.015

7 January 2021

A review of vaccine research and development: meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.015

7 January 2021

Eliminating epidemic Group A meningococcal meningitis in Africa through a new vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.015

7 January 2021

The Meningitis Vaccine Project

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.015

7 January 2021

Whom and where are we not vaccinating? Coverage after the introduction of a new conjugate vaccine against group A meningococcus in Niger in 2010

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.015

7 January 2021

Intervene before leaving: clustered lot quality assurance sampling to monitor vaccination coverage at health district level before the end of a yellow fever and measles vaccination campaign in Sierra Leone in 2009

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.015

7 January 2021

Comparison of two survey methodologies to assess vaccination coverage

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.015

7 January 2021

A study of climate change and anthropogenic impacts in West Africa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.015

7 January 2021

Estimation of design effects in cluster surveys.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.015

7 January 2021

Predictors of defaulting from completion of child immunization in south Ethiopia, May 2008: a case control study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.015

7 January 2021

Determinants of vaccination coverage in rural Nigeria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.015

7 January 2021

Childhood immunization in rural Malawi: time of administration and predictors of non-compliance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.015

7 January 2021

Measles vaccine coverage and factors related to uncompleted vaccination among 18-month-old and 36-month-old children in Kyoto, Japan

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.015

7 January 2021

Compulsory and recommended vaccination in Italy: evaluation of coverage and non-compliance between 1998-2002 in Northern Italy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.015

7 January 2021

Dynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.015

7 January 2021

Rapid identification of herd effects with the introduction of serogroup C meningococcal conjugate vaccine in Ontario, Canada, 2000-2006.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.015

7 January 2021

Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.015

7 January 2021

Dramatic decline of serogroup C meningococcal disease incidence in Catalonia (Spain) 24 months after a mass vaccination programme of children and young people

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.015

7 January 2021

Clustered lot quality assurance sampling: a pragmatic tool for timely assessment of vaccination coverage

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.01.015

7 January 2021

Identifiers

10.1016/J.VACCINE.2013.01.015

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39481684&oldid=1775255747"